Graft-derived CCL2 increases graft injury during antibody-mediated rejection of cardiac allografts

American Journal of Transplantation

Volumn 14, Issue 8, 2014, Pages 1753-1764

  Abe, T ^a,b   Su, C A ^a,c   Iida, S ^a   Baldwin, W M ^a,c   Nonomura, N ^b   Takahara, S ^b   Fairchild, R L ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloantibody; animal models; chemokines chemokine receptors; macrophage monocyte

Indexed keywords

COMPLEMENT COMPONENT C4D; GAMMA INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; ANTIBODY; CCL2 PROTEIN, MOUSE; CYTOKINE;

ANIMAL EXPERIMENT; ANTIBODY MEDIATED REJECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT INJURY; GRAFT SURVIVAL; GREAT BLOOD VESSEL; HEART GRAFT; HEART MUSCLE CAPILLARY; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY; ALLOTRANSPLANTATION; ANIMAL; BLOOD; C57BL MOUSE; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CYTOLOGY; FLOW CYTOMETRY; GENETICS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOLOGY; METABOLISM; MONOCYTE; MOUSE; TIME FACTOR;

ANIMALS; ANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CCL2; CHEMOTAXIS; CYTOKINES; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERFERON-GAMMA; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84904695472     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12780     Document Type: Article

References (42)

1. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria-an addition of the Banff '97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
2. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033-1041.
3. Berry GJ, Angelini A, Burke MM, et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005-2011). J Heart Lung Transplant 2011; 30: 601-611.
4. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011; 30: 252-269.
5. Colvin RB, Smith RN., Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807-817.
6. Gloor J, Cosio F, Lager DJ, Stegall MD., The spectrum of antibody-mediated renal allograft injury: Implications for treatment. Am J Transplant 2008; 8: 1367-1373.
7. Zhang X, Reed EF., Effect of antibodies on endothelium. Am J Transplant 2009; 9: 2459-2465.
8. Albrecht EA, Chinnaiyan AM, Varambally S, et al. C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 2004; 164: 849-859.
9. Monsinjon T, Gasque P, Chan P, Ischenko A, Brady JJ, Fontaine MC., Regulation of complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J 2003; 17: 1003-1014.
10. Fedrigo M, Feltrin G, Poli F, et al. Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection. J Heart Lung Transplant 2013; 32: 404-409.
11. Mannon RB., Macrophages: Contributors to allograft dysfunction, repair, or innocent bystantders ? Curr Opin Organ Transplant 2012; 17: 20-25.
12. Cohen HB, Mosser DM., Extrinsic and intrinsic control of macrophage inflammatory responses. J Leukoc Biol 2013; 94: 913-919.
13. Ingersoll MA, Platt AM, Potteaux S, Randolph GJ., Monocyte trafficking in acute and chronic inflammation. Trends Immunol 2011; 32: 470-477.
14. Deshmane SL, Kremlev L, Amini S, Sawaya BE., Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 2009; 29: 313-326.
15. Dawson J, Mitz W, Mir AK, Wiessner C., Targeting monocyte chemoattractant protein-1 signalling in disease. Expert Opin Ther Targets 2003; 7: 35-48.
16. Schroppel B, Zhang N, Chen P, Chen D, Bromberg JS, Murphy B., Role of donor-derived monocyte chemoattractant protein-1 in murine islet trasnplantation. J Am Soc Nephrol 2005; 16: 444-451.
17. Haskova Z, Izawa A, Contreras AG, Flynn E, Boulday G, Briscoe DM., Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection. Transplantation 2007; 83: 1595-1601.
18. Abdi R, Means TK, Ito T, et al. Differential role of CCR2 in islet and heart allograft rejection: Tissue specificity of chemokine/chemokine receptor function in vivo. J Immunol 2004; 172: 767-775.
19. Podjosudjadi W, Haha MR, Gerritsma JS, et al. Increased excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. Nephrol Dial Transplant 1996; 11: 1096-1103.
20. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Stallone G, Schena FP., Monocyte chemotactic peptide-1 expression and monocyte infiltration in actue renal transplant rejection. Transplantation 1997; 63: 414-420.
21. Farivar AS, Mackinnon-Patterson BC, McCourtie AS, Ward PA, Mulligan MS., The role of CC and CXC chemokines in cardiac allograft rejection in rats. Exp Mol Pathol 2005; 78: 171-176.
22. -/- recipients. Am J Transplant 2008; 8: 557-566.
23. Nozaki T, Amano H, Bickerstaff A, et al. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients. J Immunol 2007; 179: 5238-5245.
24. Hattori Y, Bucy RP, Kubota Y, Baldwin WM III, Fairchild RL., Antibody-mediated rejection of single class I MHC-disparate cardiac allografts. Am J Transplant 2012; 12: 2017-2028.
25. Corry RJ, Winn HJ, Russell PS., Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343-350.
26. Afanasyeva M, Georgakopoulos D, Belardi DF, et al. Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: Correlation with cardiac function. Am J Pathol 2004; 164: 807-815.
27. Schenk AD, Nozaki T, Rabant M, Valujskikh A, Fairchild RL., Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h post-transplant in naive recipients. Am J Transplant 2008; 8: 1652-1661.
28. Setoguchi K, Schenk AD, Ishi D, et al. LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. Am J Transplant 2011; 11: 923-935.
29. Berry GJ, Burke MM, Andersen C, et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standarization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2013; 32: 1147-1162.
30. Fahim T, Bohmig GA, Exner M, et al. The cellular lesion of humoral rejection: Predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007; 7: 385-393.
31. Magil AB., Monocytes/macrophages in renal allograft rejection. Transplant Rev 2009; 23: 199-208.
32. Ma FY, Woodman N, Mulley WR, Kanellis J, Nikolic-Paterson DJ., Macrophages contribute to cellular but not humoral mechanisms of acute rejection in rat renal allografts. Transplantation 2013; 96: 949-957.
33. Langenhorst D, Gogishvili T, Ribechini E, et al. Sequential induction of effector function, tissue migration and cell death during polyclonal activation of mouse regulatory T cells. PLoS ONE 2012; 7: 1-11.
34. Soler DC, Sugiyama H, Young AB, Massari JV, McCormick TS, Cooper KD., Psoriasis patients exhibit impairment of the high potency CCR5+ T regulatory cell subset. Clin Immunol 2013; 149: 111-118.
35. Tan MCB, Goedegebuure PS, Belt BAFB, et al. Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol 2009; 182: 1746-1755.
36. Mosser DM., Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
37. Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF., Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 2012; 12: 1180-1191.
38. Hidalgo LG, Sis B, Sellares J, et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvment in antibody-mediated rejection. Am J Transplant 2010; 10: 1812-1822.
39. Fuquay R, Renner B, Kulik L, et al. Renal ischemia-reperfusion injury amplifies the humoral immune response. J Am Soc Nephrol 2013; 24: 1063-1072.
40. Goto R, Issa F, Heidt S, Taggart D, Wood KJ., Ischemia-reperfusion injury accelerates human antibody-mediated transplant vasculopathy. Transplantation 2013; 96: 139-145.
41. Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P, Kunkel SL., Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induce granuloma formation: Relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol 1996; 157: 4602-4608.
42. Del Como M, Michienzi A, Masoti A, et al. CC chemokine ligand 2 down-modulation by selected Toll-like receptor agonist combinations contributes to T helper 1 polarization in human dendritic cells. Blood 2009; 114: 796-806.